Literature DB >> 23312624

Dopamine receptor D3 (DRD3) gene rs6280 variant and risk for restless legs syndrome.

Félix Javier Jiménez-Jiménez, Hortensia Alonso-Navarro, Carmen Martínez, Martín Zurdo, Laura Turpín-Fenoll, Jorge Millán, Teresa Adeva-Bartolomé, Esther Cubo, Francisco Navacerrada, Marisol Calleja, José Francisco Plaza-Nieto, Belén Pilo-de-la-Fuente, Margarita Arroyo-Solera, Ana Rojo-Sebastián, Lluisa Rubio, José A G Agúndez, Elena García-Martín.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23312624     DOI： 10.1016/j.sleep.2012.11.009

Source DB:  PubMed          Journal:  Sleep Med        ISSN： 1389-9457            Impact factor:   3.492


× No keyword cloud information.
  7 in total

1.  Reassessment of candidate gene studies for idiopathic restless legs syndrome in a large genome-wide association study dataset of European ancestry.

Authors:  Barbara Schormair; Chen Zhao; Aaro V Salminen; Konrad Oexle; Juliane Winkelmann
Journal:  Sleep       Date:  2022-08-11       Impact factor: 6.313

2.  Neuronal nitric oxide synthase (nNOS, NOS1) rs693534 and rs7977109 variants and risk for restless legs syndrome.

Authors:  Félix Javier Jiménez-Jiménez; Hortensia Alonso-Navarro; Carmen Martínez; Martín Zurdo; Laura Turpín-Fenoll; Jorge Millán-Pascual; Teresa Adeva-Bartolomé; Esther Cubo; Francisco Navacerrada; Ana Rojo-Sebastián; Lluisa Rubio; Marisol Calleja; José Francisco Plaza-Nieto; Belén Pilo-de-la-Fuente; Margarita Arroyo-Solera; Esteban García-Albea; Elena García-Martín; José A G Agúndez
Journal:  J Neural Transm (Vienna)       Date:  2014-10-10       Impact factor: 3.575

3.  A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers.

Authors:  Rafael B R León-Cachón; Jorge A Ascacio-Martínez; María E Gamino-Peña; Ricardo M Cerda-Flores; Irene Meester; Hugo L Gallardo-Blanco; Magdalena Gómez-Silva; Everardo Piñeyro-Garza; Hugo A Barrera-Saldaña
Journal:  BMC Cancer       Date:  2016-02-08       Impact factor: 4.430

4.  Impaired Sensorimotor Integration in Restless Legs Syndrome.

Authors:  Yicong Lin; Yijin Wang; Shuqin Zhan; Yan Ding; Yue Hou; Li Wang; Yuping Wang
Journal:  Front Neurol       Date:  2018-07-11       Impact factor: 4.003

5.  Common Endothelial Nitric Oxide Synthase Single Nucleotide Polymorphisms are not Related With the Risk for Restless Legs Syndrome.

Authors:  Félix Javier Jiménez-Jiménez; Blanca G Agúndez; Javier Gómez-Tabales; Hortensia Alonso-Navarro; Laura Turpín-Fenoll; Jorge Millán-Pascual; Mónica Díez-Fairén; Ignacio Álvarez; Pau Pastor; Marisol Calleja; Rafael García-Ruiz; Santiago Navarro-Muñoz; Marta Recio-Bermejo; José Francisco Plaza-Nieto; Esteban García-Albea; Elena García-Martín; José A G Agúndez
Journal:  Front Pharmacol       Date:  2021-02-25       Impact factor: 5.810

6.  Heme Oxygenase-1 and 2 Common Genetic Variants and Risk for Restless Legs Syndrome.

Authors:  Elena García-Martín; Félix Javier Jiménez-Jiménez; Hortensia Alonso-Navarro; Carmen Martínez; Martín Zurdo; Laura Turpín-Fenoll; Jorge Millán-Pascual; Teresa Adeva-Bartolomé; Esther Cubo; Francisco Navacerrada; Ana Rojo-Sebastián; Lluisa Rubio; Sara Ortega-Cubero; Pau Pastor; Marisol Calleja; José Francisco Plaza-Nieto; Belén Pilo-de-la-Fuente; Margarita Arroyo-Solera; Esteban García-Albea; José A G Agúndez
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

7.  Association Between Vitamin D Receptor rs731236 (Taq1) Polymorphism and Risk for Restless Legs Syndrome in the Spanish Caucasian Population.

Authors:  Félix Javier Jiménez-Jiménez; Elena García-Martín; Hortensia Alonso-Navarro; Carmen Martínez; Martín Zurdo; Laura Turpín-Fenoll; Jorge Millán-Pascual; Teresa Adeva-Bartolomé; Esther Cubo; Francisco Navacerrada; Ana Rojo-Sebastián; Lluisa Rubio; Sara Ortega-Cubero; Pau Pastor; Marisol Calleja; José Francisco Plaza-Nieto; Belén Pilo-De-La-Fuente; Margarita Arroyo-Solera; Esteban García-Albea; José A G Agúndez
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.